Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06557213 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

a Cohort Study (Gut Microbiota and HCC)

Name: a Cohort Study (Gut Microbiota and HCC) — clinical trial record (NCT06557213)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot specified

SponsorXu Yong, MD

Started2024-08-30

View on ClinicalTrials.gov ↗

Record status

This record was last updated August 16, 2024 (before its estimated May 20, 2026 completion). Its status may not reflect the trial's current state.

To analyze the predictive role of intestinal microbiota in tyrosine kinase inhibitors (TKIs) combined with immunotherapy response in patients with intermediate and advanced liver cancer.

Trial Details

NCT Number	NCT06557213
Lead Sponsor	Xu Yong, MD Collaborators: Nanjing Xiershou Biotechnology Co., Ltd
Conditions	Liver Cancer
Enrollment	100 participants
Start Date	2024-08-30
Primary Completion	2026-05-20 (estimated)
Study Completion	2026-11-20 (estimated)
Updated on ClinicalTrials.gov	2024-08-16